Back
Perrigo Co. Plc 10K Form
Sell
31
PRGO
Perrigo Co. Plc
Last Price:
$13.48
Seasonality Move:
1.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | PRGO/Perrigo Co. Plc Quarterly |
| 2023-11-07 | 10Q | PRGO/Perrigo Co. Plc Quarterly |
| 2023-08-08 | 10Q | PRGO/Perrigo Co. Plc Quarterly |
| 2023-05-09 | 10Q | PRGO/Perrigo Co. Plc Quarterly |
| 2022-11-08 | 10Q | PRGO/Perrigo Co. Plc Quarterly |
| 2022-08-09 | 10Q | PRGO/Perrigo Co. Plc Quarterly |
Receive PRGO News And Ratings
See the #1 stock for the next 7 days that we like better than PRGO
PRGO Financial Statistics
Sales & Book Value
| Annual Sales: | $4.4B |
|---|---|
| Cash Flow: | $29.8M |
| Price / Cash Flow: | 7.51 |
| Annual Sales: | $32.31 |
| Price / Book: | 0.43 |
Profitability
| EPS (TTM): | -0.37670 |
|---|---|
| Net Income (TTM): | $-29.1M |
| Gross Margin: | $1.5B |
| Return on Equity: | -0.66% |
| Return on Assets: | -0.29% |
Perrigo Co. Plc Earnings Forecast
Key Perrigo Co. Plc Financial Ratios
-
The Gross Profit Margin over the past 34 years for PRGO is 35.28%.
-
The Selling, General & Administrative Expenses for PRGO have been equal to 25.44% of Gross Profit Margin.
-
The Research & Development expenses have been 2.57% of Revenue.
-
The Net Earning history of PRGO is -3.67% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 23 years.
Perrigo Co. Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PRGO |
| CUSIP: | G97822 |
| Website: | perrigo.com |
Debt
| Debt-to-Equity Ratio: | 0.86 |
|---|---|
| Current Ratio: | 2.51 |
| Quick Ratio: | 0.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 4.78 |
PRGO Technical Analysis vs Fundamental Analysis
Sell
31
Perrigo Co. Plc (PRGO)
is a Sell
Is Perrigo Co. Plc a Buy or a Sell?
-
Perrigo Co. Plc stock is rated a SellThe current Perrigo Co. Plc [PRGO] share price is $13.96. The Score for PRGO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.